Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 09/30/2025 | 06/30/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00% | -0.60% | -10.42% | -10.42% | -10.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00% | -0.60% | -10.42% | -10.42% | -10.95% |
| Cost of Revenue | 1.04% | -2.31% | 1.28% | 1.28% | 4.63% |
| Gross Profit | -1.51% | 1.98% | -24.07% | -24.07% | -26.87% |
| SG&A Expenses | -3.19% | -6.29% | 31.42% | 31.42% | -18.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 22.36% | -96.39% | -158.24% | -158.24% | -136.02% |
| Total Operating Expenses | -0.10% | -7.23% | 10.87% | 10.87% | -10.97% |
| Operating Income | 1.18% | 11,275.61% | -355.52% | -355.52% | -10.74% |
| Income Before Tax | 214.77% | 180.87% | -220.83% | -220.83% | -1,242.86% |
| Income Tax Expenses | 538.70% | 100.31% | -93.89% | -93.89% | -77.11% |
| Earnings from Continuing Operations | 200.00% | 201.82% | -286.21% | -286.21% | -1,818.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 200.00% | 201.82% | -182.51% | -182.51% | -340.13% |
| EBIT | 1.18% | 11,275.61% | -355.52% | -355.52% | -10.74% |
| EBITDA | 2.30% | 121.35% | -281.90% | -281.90% | -78.51% |
| EPS Basic | 200.00% | 209.09% | -177.26% | -177.26% | -333.33% |
| Normalized Basic EPS | 214.88% | 186.72% | -265.49% | -265.49% | -1,244.12% |
| EPS Diluted | 200.00% | 209.09% | -174.68% | -174.68% | -333.33% |
| Normalized Diluted EPS | 214.88% | 186.72% | -265.49% | -265.49% | -1,244.12% |
| Average Basic Shares Outstanding | 0.00% | -6.66% | 6.76% | 6.76% | 2.91% |
| Average Diluted Shares Outstanding | 0.00% | -6.66% | 6.76% | 6.76% | 2.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |